Explore | Popular

1 investments found


Synartro develops improved treatments based on patented drug delivery technology and novel uses of drugs with proven safety and efficacy.
Funded SEK 21,270,530
Capital Target SEK 60,000,000
Max. Raise SEK 60,012,950
Min. Raise SEK 30,000,000
Percent of Equity Offered 54%
Valuation of equity SEK 52000000
End Date 10 June 2021
2 Growth Solna
View Investment